Theravance Biopharma TBPH Insider Ownership

TBPH

$17.03 +0.00 (+0.00%)

At close: Sep 25, 2026 · 4:00 PM EDT

Insider Holdings by Owner

10.61Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

0.150%

▼-6.27% pp QoQ

Shares Held by Insiders

77.66K

filed for Sep 2026

▼-97.67% QoQ

Shares Outstanding

51.89Mn

51,891,000 shares

Direct Holdings

77.66K

Indirect: 0

Net Shares Traded (QoQ)

-3.25Mn

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Over the past year, TBPH insiders sold $3.41 million of stock (192.76K shares) on the open market and bought none.

Behind Theravance Biopharma's open-market sales in the past 12 months were 2 insiders, and no insider bought.
Eran Broshy (Director) sold the most Theravance Biopharma stock on the open market over the past 12 months, $1.95 million (104K shares), most recently on November 26, 2025.
The newest open-market trade among Theravance Biopharma insiders came on September 15, 2026, when Rhonda Farnum (SVP, Comm & Medical Affairs) made a sale of 13.31K shares for $226,793.
Beyond open-market trades, insiders at Theravance Biopharma received 156.01K shares in stock awards, gave up 355.84K shares to cover taxes or exercise prices and gave away 9.9K shares as gifts in the last 12 months.
Business Quant data shows Theravance Biopharma insiders holding 77.66K shares in total in their latest Form 4 filings.
All of the 77.66K shares held by Theravance Biopharma insiders are held directly, none through trusts, partnerships or other entities.
Holdings in Theravance Biopharma stock are reported by 2 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Theravance Biopharma's two largest insider shareholders, based on their latest Form 4 filings, are Eran Broshy (Director, 44.7K shares) and Jeremy T. Grant (Director, 32.95K shares).
Eran Broshy alone accounts for 57.56% of the shares held by Theravance Biopharma insiders.
Institutional holders reported 92.45% of Theravance Biopharma's outstanding shares for Q2 2026.
In the past year, 13 insiders of Theravance Biopharma submitted 50 Form 4 filings reporting trades, awards or other transactions.
The insider data for TBPH reflects Form 4 filings through September 28, 2026.

Form 4 Holdings

Insiders Holding TBPH

Insiders 9

Shares held 10.61Mn

Of outstanding 20.45%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Eli Samaha	TenPercentOwner	0	9,167,489	9,167,489	86.4%	08 Jul, 2026
2	Andrew A. Hindman	Svp, Chief Financial Officer	384,714	0	384,714	3.6%	22 Nov, 2022
3	Kenneth R Pitzer	Svp, Prod Strat Comm Plng	380,123	0	380,123	3.6%	23 Feb, 2022
4	Richard A Graham	Svp, Research Development	314,915	0	314,915	3.0%	22 Feb, 2024
5	Ann Brady	President, Tbil	110,319	0	110,319	1.0%	23 Feb, 2022
6	Burton G Malkiel	Director	100,589	0	100,589	0.9%	04 May, 2023
7	William D Young	Director	78,010	0	78,010	0.7%	28 Apr, 2022
8	Eran Broshy	Director	44,703	0	44,703	0.4%	01 Dec, 2025
9	Jeremy T Grant	Director	32,954	0	32,954	0.3%	21 May, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

853 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
23 Sep, 2026	Asset Management Lp Weiss	Other	Disposed J	7,457,060	$17.00	$126.77Mn	0	Indirect
23 Sep, 2026	Brett A. Grimaud	Svp, Gen Counsel And Secretary	Disposed D	223,917	—	—	131,251	Direct
23 Sep, 2026	Alsup Laurie Smaldone	Director	Disposed D	74,980	—	—	6,009	Direct
23 Sep, 2026	Dean J Mitchell	Director	Disposed D	91,204	—	—	6,009	Direct
23 Sep, 2026	Rick E Winningham	Chief Executive Officer	Disposed D	1,382,272	—	—	228,750	Direct
23 Sep, 2026	Aziz Sawaf	Svp Chief Financial Officer	Disposed D	204,966	—	—	131,875	Direct
23 Sep, 2026	Aine Miller	Svp, Dev Head Of Ire Office	Disposed D	93,108	—	—	96,718	Direct
23 Sep, 2026	Donal O'Connor	Director	Disposed D	74,204	—	—	6,009	Direct
23 Sep, 2026	Deepika Pakianathan	Director	Disposed D	58,065	—	—	6,009	Direct
23 Sep, 2026	Rhonda Farnum	Svp, Comm Medical Affairs	Disposed D	124,414	—	—	89,062	Direct
23 Sep, 2026	Susannah Gray	Director	Disposed D	42,137	—	—	6,009	Direct
23 Sep, 2026	Brett A. Grimaud	Svp, Gen Counsel And Secretary	Disposed D	107,812	—	—	23,439	Direct
23 Sep, 2026	Susannah Gray	Director	Disposed D	6,009	—	—	0	Direct
23 Sep, 2026	Alsup Laurie Smaldone	Director	Disposed D	6,009	—	—	0	Direct
23 Sep, 2026	Aziz Sawaf	Svp Chief Financial Officer	Disposed D	108,436	—	—	23,439	Direct
23 Sep, 2026	Rick E Winningham	Chief Executive Officer	Disposed D	151,875	—	—	76,875	Direct
23 Sep, 2026	Rhonda Farnum	Svp, Comm Medical Affairs	Disposed D	89,062	—	—	0	Direct
23 Sep, 2026	Dean J Mitchell	Director	Disposed D	6,009	—	—	0	Direct
23 Sep, 2026	Deepika Pakianathan	Director	Disposed D	6,009	—	—	0	Direct
23 Sep, 2026	Donal O'Connor	Director	Disposed D	6,009	—	—	0	Direct

Showing 1 to 20 of 853 transactions